Cytokinetics | CYTK - Stock

Aktienkurs
66.81
Täglich Wechseln
1.33 2.03%
Monatlich
7.03%
Jährlich
79.02%
Q2 Prognose
64.72




Stock Veränderung Datum
Acadia Pharmaceuticals USD 34.67M 5.57M 2025-12
Amgen USD 6.22B 121M 2025-12
Bayer EUR 12.33B 221M 2025-09
Biogen USD 2.17B 41.3M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Cytokinetics USD 0 0 2023-12
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Exelixis USD 27.4M 3.92M 2025-09
Geron USD 116.64M 21.21M 2025-12
Halozyme Therapeutics USD 176.48M 9.32M 2025-12
Ionis Pharmaceuticals USD 10.47M 1.99M 2025-09
Ligand Pharmaceuticals USD 9.13M 2.77M 2025-12
Merck USD 6.44B 157M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12